Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 44,936,532	$ 24,681,301
Acquired in-process research and development	0	1,754,265
General and administrative	11,283,004	9,985,454
Loss from operations	(56,219,536)	(36,421,020)
Other income (expense):
Interest income	185,363	292,224
Interest expense	(1,742,101)	(1,904,198)
Total other income (expense), net	(1,556,738)	(1,611,974)
Loss before income taxes	(57,776,274)	(38,032,994)
Income tax benefit	0	(479,265)
Net loss	$ (57,776,274)	$ (37,553,729)
Net loss per share - basic and diluted	$ (1.07)	$ (1.11)
Weighted average common shares outstanding - basic and diluted	54,042,103	33,965,955